Baseline differences may impact on relationship between dietary tryptophan and risk of obesity and type 2 diabetes

doi:10.12998/wjcc.v10.i21.7617

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 21

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3395)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-1) series.

Item

Count

PDF

123

WORD

HTML

1817

Tables (1-1)

216

Sum=2231

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

351

Download

813

Sum=1164

Jul 26, 2022 (publication date) through Jul 23, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Letter to the Editor

World J Clin Cases. Jul 26, 2022; 10(21): 7617-7619
Published online Jul 26, 2022. doi: 10.12998/wjcc.v10.i21.7617

Table 1 Baseline characteristics of study variables by tertiles of cumulative tryptophan intake in CHNS, 1997-2011[2]

Baseline variable	T1 (n = 2633)	T2 (n = 2642)	T3 (n = 2633)	P value
Age (yr)	43.884 (14.624)	43.196 (14.787)	43.338 (15.187)	0.207
Female, n (%)	1296 (49.221)	1338 (50.643)	1330 (50.513)	0.521
BMI (kg/m²)	22.818 (2.966)	22.344 (2.957)	21.668 (2.669)	< 0.001
WHR	0.852 (0.066)	0.847 (0.061)	0.845 (0.061)	< 0.001
PAL (MET-h/wk)	306.102 (185.951)	305.386 (183.797)	314.724 (178.567)	0.119
Energy intake (kcal/d)	2406.574 (730.597)	2279.742 (631.699)	2312.202 (619.281)	< 0.001
Protein intake (g/d)	75.854 (24.496)	68.007 (21.007)	63.132 (19.504)	< 0.001
Fat intake (g/d)	65.010 (37.716)	71.561 (36.944)	60.339 (32.443)	< 0.001
Carbohydrate intake (g/d)	376.755 (142.836)	337.802 (113.510)	375.947 (115.997)	< 0.001
SBP (mmHg)	120.945 (17.845)	118.362 (17.904)	116.824 (17.303)	< 0.001
DBP (mmHg)	78.296 (10.763)	77.051 (11.277)	75.871 (10.419)	< 0.001
Baseline tryptophan consumption (mg/g protein)	12.660 (0.972)	13.812 (1.018)	14.947 (1.216)	< 0.001
Living in city, n (%)	761 (28.902)	942 (35.655)	581 (22.066)	< 0.001
Urban index	51.952 (2.951)	52.032 (2.732)	51.797 (2.657)	0.008
Individual income (yuan)	6019.137 (6773.845)	6390.557 (5712.462)	5325.567 (5445.487)	< 0.001
High school education, n (%)	457 (17.357)	570 (21.575)	347 (13.179)	< 0.001
Smoking, n (%)	886 (33.650)	889 (33.649)	853 (32.397)	0.537
Drinking, n (%)	1008 (38.283)	995 (37.661)	903 (34.295)	0.005
Sleep time (h)	8.085 (1.135)	8.098 (1.179)	8.215 (1.161)	< 0.001
Prevalent diabetes, n (%)	32 (1.215)	38 (1.438)	49 (1.861)	0.148
Prevalent obesity, n (%)	162 (6.153)	114 (4.315)	69 (2.621)	< 0.001
Prevalent overweight, n (%)	540 (20.509)	472 (17.865)	274 (10.406)	< 0.001
Prevalent hypertension, n (%)	554 (21.041)	478 (18.092)	391 (14.850)	< 0.001

BMI: Body mass index; WHR: Waist-hip ratio; PAL: Peer-assisted learning; SBP: Systolic blood pressure; DBP: D binding protein.

Citation: Ren XH, Ye YW, He LP. Baseline differences may impact on relationship between dietary tryptophan and risk of obesity and type 2 diabetes. World J Clin Cases 2022; 10(21): 7617-7619
URL: https://www.wjgnet.com/2307-8960/full/v10/i21/7617.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i21.7617